Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(6;12)(p21;q24) EP400/PHF1

Written2018-01Jean-Loup Huret, Philippe Dessen

(Note : for Links provided by Atlas : click)


Atlas_Id 6618
Phylum Soft Tissue::
Note Non-annotated chromosomal abnormality. Preliminary data :
if you are an author who wish to write a full paper/card on this gene, go to  How to contribute

Clinics and Pathology

Disease Soft Tissue:Soft Tissue tumours: Uncertain differentiation: Ossifying fibromyxoid tumour: t(6;12)(p21;q24) EP400/PHF1

Genes involved and Proteins

Gene NameEP400
Location 12q24.33

Gene NamePHF1
Location 6p21.32


Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors
Gebre-Medhin S, Nord KH, Möller E, Mandahl N, Magnusson L, Nilsson J, Jo VY, Vult von Steyern F, Brosjö O, Larsson O, Domanski HA, Sciot R, Debiec-Rychter M, Fletcher CD, Mertens F
Am J Pathol 2012 Sep;181(3):1069-77
PMID 22796436
Ossifying fibromyxoid tumor presenting EP400-PHF1 fusion gene
Endo M, Kohashi K, Yamamoto H, Ishii T, Yoshida T, Matsunobu T, Iwamoto Y, Oda Y
Hum Pathol 2013 Nov;44(11):2603-8
PMID 23806526

Translocations implicated (Data extracted from papers in the Atlas)

 t(6;12)(p21;q24) EP400/PHF1

External links

Mitelman database t(6;12)(p21;q24) [CaseList]    t(6;12)(p21;q24) [Transloc - MCList] EP400/PHF1 [Fusion - MCList]
COSMIC[ EP400 ]   [ PHF1 ]
arrayMap arrayMap ((UZH-SIB Zurich)   [auto + random 100 samples .. if exist ]   [tabulated segments]
Disease databaset(6;12)(p21;q24) EP400/PHF1
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Fri Mar 9 17:59:08 CET 2018

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us